Arun Ravindran

Active 1995–2026

135
Papers
18,805
Citations
66
h-index
101
i10-index

Citations

Citations per year for Arun Ravindran1975: 1 citations1995: 1 citations1997: 4 citations1998: 2 citations1999: 15 citations2000: 22 citations2001: 34 citations2002: 42 citations2003: 37 citations2004: 35 citations2005: 58 citations2006: 53 citations2007: 47 citations2008: 57 citations2009: 115 citations2010: 81 citations2011: 78 citations2012: 101 citations2013: 92 citations2014: 75 citations2015: 105 citations2016: 151 citations2017: 105 citations2018: 135 citations2019: 498 citations2020: 646 citations2021: 549 citations2022: 537 citations2023: 465 citations2024: 757 citations2025: 328 citations2026: 30 citations1976–1994: no citations, so these years are not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,451 citing papers, 18.8% of this breakdownCanada: 899 citing papers, 11.7% of this breakdownChina: 648 citing papers, 8.4% of this breakdownUnited Kingdom: 524 citing papers, 6.8% of this breakdownAustralia: 345 citing papers, 4.5% of this breakdownGermany: 324 citing papers, 4.2% of this breakdownItaly: 322 citing papers, 4.2% of this breakdownSpain: 284 citing papers, 3.7% of this breakdownBrazil: 220 citing papers, 2.9% of this breakdownNetherlands: 209 citing papers, 2.7% of this breakdownFrance: 172 citing papers, 2.2% of this breakdownJapan: 149 citing papers, 1.9% of this breakdown
0%18.8%Other 28%

Fields

  • Medicine55%
  • Neuroscience20.5%
  • Psychology11.8%
  • Biochemistry, Genetics and Molecular Biology3.6%
  • Computer Science3.1%
  • Engineering1.6%
  • Other4.4%

Topics

  • Treatment of Major Depression9.5%
  • Bipolar Disorder and Treatment7.1%
  • Tryptophan and brain disorders7%
  • Schizophrenia research and treatment3.9%
  • Electroconvulsive Therapy Studies3.3%
  • Stress Responses and Cortisol3%
  • Other66.2%

Coauthors

All papers

Open in search
  1. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Bipolar Disorders 2018 cited by 1,770

  2. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies

    Authors: , , , , , , , , , , , , - Molecular Psychiatry 2019 cited by 870

  3. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    Authors: , , , , , , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 cited by 1,123

  4. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

    Authors: , , , , , , , , , , , , , , , , , - The International Journal of Neuropsychopharmacology 2019 cited by 590

  5. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2016 cited by 737

  6. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    Authors: , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 cited by 583

  7. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Berk - The World Journal of Biological Psychiatry 2022 cited by 198

  8. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2020 cited by 351

  9. Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyle Medicine (ASLM) taskforce

    Authors: , , , , , , , , , , , , , , , - The World Journal of Biological Psychiatry 2022 cited by 158

  10. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents

    Authors: , , , , , , , , , , , , , , - Molecular Psychiatry 2018 cited by 181

  11. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update

    Authors: , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2023 cited by 104

  12. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kathryn Schade, Ayal Schaffer, Mark Sinyor, Cláudio N. Soares, Jennifer Swainson, Valerie H. Taylor, Smadar Valérie Tourjman, Rudolf Uher, Michael Van Ameringen, Gustavo Vázquez, Simone N. Vigod, Daphne Voineskos, Lakshmi N. Yatham, Roumen Milev - The Canadian Journal of Psychiatry 2024 cited by 303

  13. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    Authors: , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 cited by 578

  14. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L’humeur Et De L’anxiété (Canmat) Concernant L’utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur

    Authors: , , , , , , , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2020 cited by 108

  15. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    Authors: , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 cited by 296

  16. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    Authors: , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 cited by 331

  17. GenSQLi: A Generative Artificial Intelligence Framework for Automatically Securing Web Application Firewalls Against Structured Query Language Injection Attacks

    Authors: , - Future Internet 2024 cited by 23

  18. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    Authors: , , , , , , , , , , , - The Canadian Journal of Psychiatry 2016 cited by 250

  19. Depression, Anxiety, and Other Mental Disorders in Patients With Cancer in Low- and Lower-Middle–Income Countries: A Systematic Review and Meta-Analysis

    Authors: , , , - JCO Global Oncology 2021 cited by 100

  20. Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis

    Authors: , , , , , , , , , , - The International Journal of Neuropsychopharmacology 2015 cited by 196

  21. Mez: An Adaptive Messaging System for Latency-Sensitive Multi-Camera Machine Vision at the IoT Edge

    Authors: , , , - IEEE Access 2021 cited by 71

  22. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder

    Authors: , , , , , , , , , , , , , , , , , , , , - The Canadian Journal of Psychiatry 2022 cited by 56

  23. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - 2019 cited by 219

  24. Cannabis Use and Prospective Long-Term Association with Anxiety: A Systematic Review and Meta-Analysis of Longitudinal Studies: Usage du cannabis et association prospective à long terme avec l’anxiété: une revue systématique et une méta-analyse d’études longitudinales

    Authors: , , , - The Canadian Journal of Psychiatry 2020 cited by 60